Compare IKT & ALPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
Alpine 4 Holdings Inc is a holding company that acquires businesses in several industry segments namely Aerospace, Battery Tech, Defense Services, Technology, and Manufacturing, as either a Driver, Stabilizer, or Facilitator from the company's disruptive DSF business model. It focuses on how the incorporation of new technologies can drive innovation even in brick-and-mortar businesses, with an understanding of how technology and innovation can enhance businesses.